Sentences with phrase «as pharmaceutical litigation»

Multidistrict litigation is a procedure used to help effectively handle complex legal proceedings such as pharmaceutical litigation.

Product liability for medications that cause injury is also known as pharmaceutical litigation when the manufacturer produces a defective drug.

Not exact matches

She says she is typically involved with consumer litigation such as price - fixing and pharmaceutical cases and notes this case was different.

With deep experience in product liability matters and class action litigation, including catastrophic injury and wrongful death cases, as well as consumer fraud, he represents national and international companies, including manufacturers of motor vehicles, power tools, pharmaceuticals, clothing, glass products, outdoor power equipment, and industrial machinery.

Our firm is respected as a leader in products liability litigation and has a solid history of successfully representing plaintiffs in pharmaceutical litigation.

Contact the pharmaceutical litigation attorneys at Arias Sanguinetti Wang & Torrijos if you believe you have suffered injuries as a result of taking Fosamax.

As an attorney with the New York litigation firm of Whitman Breed Abbott & Morgan (1990 - 2000), Mr. Scagnelli handled intellectual property counseling work and litigation for industrial clients, including Pharmaceutical Formulations, Inc. in Edison, New Jersey, then the second largest private label pharmaceutical company in the United States.

This blawg «reports on Hatch - Waxman litigation and other pharmaceutical patent cases, as well as regulatory and legislative developments.»

Fred Roth, an associate in Chicago, has experience working on litigation and regulatory compliance as it applies to medical devices and pharmaceuticals.

As one of the nation's leading lawyers in the emerging field of state unclaimed property laws, John devotes a substantial part of his practice to representing and advising a variety of manufacturers, retailers, distributors, financial institutions, pharmaceutical companies, telecommunications and transportation companies, utilities, service providers and other types of businesses on complex multi-state unclaimed property audits, litigation, voluntary disclosure agreements and transactional issues.

She has extensive experience defending domestic and international medical device and pharmaceutical manufacturers in multi-plaintiff actions, as well as hospitals and physicians in medical malpractice actions in all stages of litigation, including trial.

In cases involving the Hatch - Waxman Act and issues involving the expiration of pharmaceutical patents and competition between branded drug companies and generic manufacturers, our antitrust litigation graphics can illuminate a complicated industry and a complex regulatory scheme as below:

Served as litigation counsel for major pharmaceutical company in test case of nationwide significance, involving allegations of Medicaid fraud.

Serve as national counsel for a major pharmaceutical company in all aspects of its HRT litigation.

Sindhu Daniel manages the firm's Pharmaceutical Litigation Group and has a passion for representing people harmed by big pharmaceutical companies which have marketed their products as safe when they are not or have otherwise misrepresented the efficacy and toxicity of their medical commodities.

Currently, Ms. Butler focuses on pharmaceutical litigation, as well as whistleblower / qui tam cases and Medicare fraud cases.

With experience litigating both criminal and civil trials as well as appeals, Alan represents clients in matters such as pharmaceutical and medical device (criminal and civil investigations), False Claims Act litigation, antitrust cartel investigations, and tax and accounting fraud investigations.

He also represents pharmaceutical and bio-tech companies as plaintiffs and defendants in international and domestic arbitrations and litigation regarding commercial practices and pricing, milestones, contracts, and partnerships.

Mr. Geiger represents business clients in all types of disputes, such as product liability (including pharmaceuticals and medical devices), toxic torts, medical and genetics negligence, breach of privacy, other personal injury claims, class actions, multidistrict litigation, governmental actions, insurance litigation, breaches of contract, allegations of fraud and unfair trade practices, commercial warranty disputes and intellectual property controversies.

As we reported, Canada implemented a single - track pharmaceutical patent litigation regime through amendments to the Patented Medicines (Notice of Compliance) Regulations (the Regulations) on September 21, 2017.

As the head of Baron & Budd's asbestos and pharmaceutical litigation teams, Baron has helped build the firm's reputation as a watchdog for consumer protectioAs the head of Baron & Budd's asbestos and pharmaceutical litigation teams, Baron has helped build the firm's reputation as a watchdog for consumer protectioas a watchdog for consumer protection.

We have been involved in the development of group litigation in the UK, as pharmaceutical and healthcare product liability cases are often, by their nature, repercussive.

The publication highlights some of the firm's high - profile representations, including its role as lead national counsel for an international pharmaceutical company in hormone replacement therapy litigation, Wright's representation of Ford against allegations of unintended acceleration and faulty spark plugs, and Troyer's defense of Wells Fargo in a nationwide class action and an associated individual action and his representation of a manufacturing company in a toxic tort case.

Vermont litigation attorneys Chris Maley and John Maley represent those who are injured or killed as a result of defective drugs manufactured and distributed by pharmaceutical companies and defective medical device manufacturers.

Complex pharmaceutical litigation, as well as complicated questions of contract law arose.

His experience in these areas stems from his time at the venerated plaintiffs» law firm Lopez, Hodes, Restaino, Milman & Skikos, where he handled high - profile mass tort litigation and pharmaceutical injury cases against such behemoth companies as Wal - mart, Merck & Co. and Halliburton Company.

Defending a pharmaceutical manufacturer as part of a King & Spalding team serving as national co-counsel and trial counsel in nationwide litigation.

Our reputation as one of the top class action defense firms in the country results from our significant experience in defending against alleged class actions across a broad range of pharmaceutical and other products litigation, as well as antitrust, employment and securities litigation.

Mr. Weir has also served as statewide counsel for pharmaceutical manufacturers defending the pharmaceutical manufacturers in class - action litigation.

Mr. Girard currently serves on the leadership team in the Target and Sony data breach actions; serves as lead counsel in derivative litigation on behalf of Wal - Mart shareholders arising out of alleged bribery in Mexico, lead counsel for commodities investors in litigation arising out of the collapse of a commodities futures merchant, and lead counsel in a multi-district «pay for delay» antitrust proceeding against major pharmaceutical companies.

Our present and recent engagements as national coordinating counsel in major pharmaceutical and medical device litigation involve numerous products for many of the world's largest pharmaceutical manufacturers.

The key patent cases that I have to address and consider currently in the chemical, pharmaceutical and biotechnological cases (however, it should be appreciated there are several more) are the recent Alice (patent subject matter eligibility), Shaw Industries Group, Inc. (accused infringers can use AIA review procedures without undermining their case in later litigation), Merck & Cie (PTAB AIA review decisions must be reviewed with deference on appeal) and In re Cuozzo Speed Technologies, LLC, (broadest reasonable interpretation for IPR versus ordinary meaning for litigation is appropriate) decisions as well as the USPTO's ever developing guidelines as to patent subject matter eligibility and obviousness determinations.

For many intellectual property firms, concerns pharmaceutical litigation would dry up, removing a core source of income for many, appear to be as yet unfounded.

Such honors flow from years of experience handling personal injury litigation arising from pharmaceutical products, medical devices, consumer products, and equipment, as well as from chemical and transportation exposures, accidents, and explosions.

In product liability litigation, we represent pharmaceutical and medical device makers and distributors in all aspects of national and international litigation as: (a) lead trial counsel, (b) national or global coordinating counsel, (c) resolution counsel, and (d) appellate counsel.

She has served as local counsel on more than 20 cases for a pharmaceutical company in MDL litigation in which she again deposed dozens of prescribing and treating physicians and their patients.

Representation of a global Fortune 50 pharmaceutical company as its primary e-discovery counsel; he counsels the company on litigation readiness, information management, data privacy and international discovery issues